Ammoxetine attenuates diabetic neuropathic pain through inhibiting microglial activation and neuroinflammation in the spinal cord

BACKGROUND: Diabetic neuropathic pain (DNP) is a common and distressing complication in patients with diabetes, and the underlying mechanism remains unclear. Tricyclic antidepressants (TCAs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) are recommended as first-line drugs for DNP. Amm...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neuroinflammation
Main Authors: Zhang, Ting-Ting, Xue, Rui, Fan, Shi-Yong, Fan, Qiong-Yin, An, Lei, Li, Juan, Zhu, Lei, Ran, Yu-Hua, Zhang, Li-Ming, Zhong, Bo-Hua, Li, Yun-Feng, Ye, Cai-Ying, Zhang, You-Zhi
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5992688/
https://ncbi.nlm.nih.gov/pubmed/29879988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-018-1216-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados